The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection

Sponsor
Kyungpook National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05046054
Collaborator
(none)
80
1
2
8
10

Study Details

Study Description

Brief Summary

Propofol, an intravenous sedative agent, frequently produces pain during injection. This study was designed to investigate whether transcutaneous electrical nerve stimulation could reduce pain during propofol injection.

in minimizing propofol injection pain.

Condition or Disease Intervention/Treatment Phase
  • Device: transcutaneous electrical nerve stimulation
  • Device: Placebo transcutaneous electrical nerve stimulation
N/A

Detailed Description

Twenty min after transcutaneous electrical nerve stimulation, the electrodes were removed and propofol 0.5 mg/kg was administered at the rate of 0.5 ml/sec using syringe pump. Propofol injection pain was evaluated by a study blinded anesthesiologist using a four point scale: 0=no (negative response to questioning), 1=mild pain (pain reported only in response to questioning without any behavioral sings), 2=moderate pain (pain reported in response to questioning and accompanied by a behavioral signs or pain reported spontaneously without questioning, 3=severe pain (strong vocal response or response accompanied by facial grimacing, arm withdrawal or tears).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
TENS YW-5000 (YoungWon Medical Co, Korea)TENS YW-5000 (YoungWon Medical Co, Korea)
Masking:
Single (Investigator)
Masking Description:
Two electrodes were attached to the radial side of dominant forearm. In the placebo group the TENS device had no current output although the power "on" indicator light remained active.
Primary Purpose:
Prevention
Official Title:
The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection
Actual Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Jan 30, 2022
Anticipated Study Completion Date :
Jan 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: transcutaneous electrical nerve stimulation group

Transcutaneous electrical nerve stimulation was givent via two electrodes on the venous cannulation site 20 min before propofol injection

Device: transcutaneous electrical nerve stimulation
transcutaneous electrical nerve stimulation group received transcutaneous electrical nerve stimulation via two electrodes on the venous cannulation site 20 min before propofol injection

Placebo Comparator: control group

No transcutaneous electrical nerve stimulation was not given via two electrodes on the venous cannulation site 20 min before propofol injection

Device: Placebo transcutaneous electrical nerve stimulation
Placebo transcutaneous electrical nerve stimulation group received no transcutaneous electrical nerve stimulation via two electrodes on the venous cannulation site 20 min before propofol injection

Outcome Measures

Primary Outcome Measures

  1. pain during propofol injection [15 seconds]

    Propofol injection pain was evaluated by a study blinded anesthesiologist using a four point scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Exclusion Criteria:
  • American Society of Anesthesiologists physical status classification > 3

  • Patient with a history of allergy to drugs

  • Patient who takes opioid, sedative, anticonvulsant

  • Patient with a history of neurologic disease and psychological disorders

  • patient with skin problem

  • Patient with pacemaker or electric medical device

  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kyungpook National university hospital Daegu Korea, Republic of 41944

Sponsors and Collaborators

  • Kyungpook National University Hospital

Investigators

  • Principal Investigator: Younghoon Jeon, Kyungpook National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Younghoon Jeon, Professor, Kyungpook National University Hospital
ClinicalTrials.gov Identifier:
NCT05046054
Other Study ID Numbers:
  • 2021-03-036-001
First Posted:
Sep 16, 2021
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 19, 2022